Literature DB >> 12920526

Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane.

Carolin A Gass1, Christos Haritoglou, Markus Schaumberger, Anselm Kampik.   

Abstract

PURPOSE: To describe the impact of indocyanine green (ICG) staining of the internal limiting membrane (ILM) on the functional outcome of anatomically successful macular hole surgery by comparing consecutive patient series with and without ILM staining.
METHODS: Eighteen consecutive patients who had undergone ICG-assisted vitrectomy (0.05%) for idiopathic macular hole were retrospectively analysed (visual acuity, gain in lines, Goldmann perimetry) and compared with two consecutive series of patients who had undergone macular hole surgery without the use of ICG immediately before (n=22) and after (n=17) the introduction of ICG in our institution. The osmolarity of the ICG solution applied was 275 mosmol, pH was 7.5.
RESULTS: Although there was no statistically significant difference in duration of preoperative symptoms (P>0.3) and preoperative visual acuity (P>0.5), the functional outcome in patients after ICG-assisted vitrectomy was significantly lower (P<0.001 for visual acuity). The incidence of visual field defects was 50% (9/18) in patients after ICG application.
CONCLUSION: Our findings suggest potential damage to the neurosensory retina in association with the intraoperative administration of the ICG solution. Whether this is caused by toxic effects of the dye itself, mechanical trauma to the retina or other mechanisms remains unknown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920526     DOI: 10.1007/s00417-003-0710-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

1.  Counterpoint: to peel or not to peel: is that the question?

Authors:  Tarek S Hassan; George A Williams
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

2.  Point: to peel or not to peel, that is the question.

Authors:  Ferenc Kuhn
Journal:  Ophthalmology       Date:  2002-01       Impact factor: 12.079

3.  Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent.

Authors:  Peter Stalmans; Elisabeth H Van Aken; Marc Veckeneer; Eric J Feron; Ingeborg Stalmans
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

4.  Idiopathic senile macular hole. Its early stages and pathogenesis.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1988-05

5.  Indocyanine green selectively stains the internal limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-03       Impact factor: 5.258

6.  Peripheral visual field defects after macular hole surgery: a complication with decreasing incidence.

Authors:  C A Gass; C Haritoglou; E M Messmer; M Schaumberger; A Kampik
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

7.  Long-term follow-up after macular hole surgery with internal limiting membrane peeling.

Authors:  Christos Haritoglou; Carolin A Gass; Markus Schaumberger; Arnd Gandorfer; Michael W Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

8.  Staining of internal limiting membrane in macular hole surgery.

Authors:  K Kadonosono; N Itoh; E Uchio; S Nakamura; S Ohno
Journal:  Arch Ophthalmol       Date:  2000-08

9.  Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage.

Authors:  A Gandorfer; C Haritoglou; C A Gass; M W Ulbig; A Kampik
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

10.  [Surgical management of complete macular foramina].

Authors:  O Liesenhoff; E M Messmer; A Pulur; A Kampik
Journal:  Ophthalmologe       Date:  1996-12       Impact factor: 1.059

View more
  26 in total

1.  [Retinal ICG-accumulation after ILM-staining during macular hole surgery?].

Authors:  I Krömer; A Lommatzsch; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  Retinal nerve fibre layer damage after indocyanine green assisted vitrectomy.

Authors:  A Iriyama; Y Yanagi; S Uchida; Y Tamaki; M Aihara; R Obata; Y Inoue
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Paracentral retinal holes occurring after macular surgery: incidence, clinical features, and evolution.

Authors:  Otman Sandali; Mohamed El Sanharawi; Elena Basli; Nicolas Lecuen; Sebastien Bonnel; Vincent Borderie; Laurent Laroche; Claire Monin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-27       Impact factor: 3.117

4.  Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery.

Authors:  Aude Husson-Danan; Agnès Glacet-Bernard; Gisèle Soubrane; Gabriel Coscas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03       Impact factor: 3.117

Review 5.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

6.  Chromovitrectomy: a new field in vitreoretinal surgery.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Peter Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

7.  [Anatomical and functional results after elective macular surgery].

Authors:  A Hager; S Ehrich; W Wiegand
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

8.  Let green lead not astray.

Authors:  J Sebag
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

9.  A novel applicator for the selective painting of pre-retinal structures during vitreoretinal surgery.

Authors:  Carsten H Meyer; Eduardo B Rodrigues
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

10.  Relationship between macular hole size and the potential benefit of internal limiting membrane peeling.

Authors:  R Tadayoni; A Gaudric; B Haouchine; P Massin
Journal:  Br J Ophthalmol       Date:  2006-06-29       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.